SeaStar Medical Holding Corp
ICU0.352USD
-0.623-63.89%
Close 06/20, 16:00（ET）Quotes delayed by 15 min
3.26MMarket Cap
LossP/E TTM
More Details of SeaStar Medical Holding Corp Company
SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).
Company Info
Ticker SymbolICU
Company nameSeaStar Medical Holding Corp
IPO dateJan 26, 2021
Founded at2020
CEOMr. Eric Schlorff
Number of employees19
Security typeOrdinary Share
Fiscal year-endJan 26
Address3513 Brighton Blvd
CityDENVER
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80216
Phone18444278100
Websitehttps://seastarmedical.com
Ticker SymbolICU
IPO dateJan 26, 2021
Founded at2020
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
40.00K
--
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Director
Chief Executive Officer, Director
33.52K
+0.03%
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
18.18K
-0.01%
Mr. David A. Green, CPA
Mr. David A. Green, CPA
Chief Financial Officer
Chief Financial Officer
16.32K
+2.35%
Ms. Jennifer A (Jen) Baird
Ms. Jennifer A (Jen) Baird
Independent Director
Independent Director
10.00K
--
Mr. Allan Collins, M.D.
Mr. Allan Collins, M.D.
Independent Director
Independent Director
3.63K
--
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Mr. Richard (Rick) Barnett
Mr. Richard (Rick) Barnett
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Bernadette N Vincent
Ms. Bernadette N Vincent
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
40.00K
--
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Director
Chief Executive Officer, Director
33.52K
+0.03%
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
18.18K
-0.01%
Mr. David A. Green, CPA
Mr. David A. Green, CPA
Chief Financial Officer
Chief Financial Officer
16.32K
+2.35%
Ms. Jennifer A (Jen) Baird
Ms. Jennifer A (Jen) Baird
Independent Director
Independent Director
10.00K
--
Mr. Allan Collins, M.D.
Mr. Allan Collins, M.D.
Independent Director
Independent Director
3.63K
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, May 24
Updated: Sat, May 24
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Armistice Capital LLC
5.79%
Geode Capital Management, L.L.C.
0.70%
The Vanguard Group, Inc.
0.54%
Neuman (John)
0.38%
Tyche Wealth Partners LLC
0.36%
Other
92.23%
Shareholders
Shareholders
Proportion
Armistice Capital LLC
5.79%
Geode Capital Management, L.L.C.
0.70%
The Vanguard Group, Inc.
0.54%
Neuman (John)
0.38%
Tyche Wealth Partners LLC
0.36%
Other
92.23%
Shareholder Types
Shareholders
Proportion
Hedge Fund
5.81%
Investment Advisor/Hedge Fund
1.37%
Individual Investor
1.24%
Investment Advisor
1.04%
Research Firm
0.15%
Venture Capital
0.12%
Bank and Trust
0.05%
Other
90.24%
Institutional Shareholding
Updated: Mon, Mar 3
Updated: Mon, Mar 3
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
61
477.30K
4.75%
+4.73K
2024Q4
56
403.35K
5.53%
-59.49K
2024Q3
101
532.19K
15.84%
-408.40K
2024Q2
105
549.58K
17.81%
-317.45K
2024Q1
106
490.37K
46.99%
-245.21K
2023Q4
100
525.53K
64.26%
-360.30K
2023Q3
92
529.03K
69.17%
-298.51K
2023Q2
88
487.42K
67.26%
-347.45K
2023Q1
83
499.78K
93.97%
-289.56K
2022Q4
79
481.07K
96.76%
-320.84K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Geode Capital Management, L.L.C.
45.43K
0.52%
+5.62K
+14.11%
Dec 31, 2024
The Vanguard Group, Inc.
91.41K
1.05%
+21.09K
+29.99%
Dec 31, 2024
Neuman (John)
40.00K
0.46%
+10.00K
+33.33%
Dec 11, 2024
Schlorff (Eric)
49.71K
0.57%
+495.00
+1.01%
Feb 11, 2025
Chung (Kevin)
7.49K
0.09%
-4.25K
-36.22%
Feb 11, 2025
Green (David A)
15.20K
0.17%
+4.88K
+47.22%
Feb 11, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jun 06, 2024
Merger
25<1
Jun 06, 2024
Merger
25<1
Jun 06, 2024
Merger
25<1
Jun 06, 2024
Merger
25<1
Date
Type
Ratio
Jun 06, 2024
Merger
25<1
Jun 06, 2024
Merger
25<1
Jun 06, 2024
Merger
25<1
Jun 06, 2024
Merger
25<1
